Safety and Efficacy Study of NBI-98854 in Adults With Tourette Syndrome
Clinical trial NCT02581865 · COMPLETED
Trial details
- NCT number
- NCT02581865
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-12-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.